{"id":2285,"date":"2025-12-30T17:50:47","date_gmt":"2025-12-30T17:50:47","guid":{"rendered":"https:\/\/journal.nncf.kz\/?p=2285"},"modified":"2026-03-11T17:52:57","modified_gmt":"2026-03-11T17:52:57","slug":"%d0%be%d1%85%d0%b2%d0%b0%d1%82-%d0%b2%d0%b0%d0%ba%d1%86%d0%b8%d0%bd%d0%b0%d1%86%d0%b8%d0%b5%d0%b9-%d0%bf%d1%80%d0%be%d1%82%d0%b8%d0%b2-%d1%82%d1%83%d0%b1%d0%b5%d1%80%d0%ba%d1%83%d0%bb%d0%b5%d0%b7","status":"publish","type":"post","link":"https:\/\/journal.nncf.kz\/en\/%d0%be%d1%85%d0%b2%d0%b0%d1%82-%d0%b2%d0%b0%d0%ba%d1%86%d0%b8%d0%bd%d0%b0%d1%86%d0%b8%d0%b5%d0%b9-%d0%bf%d1%80%d0%be%d1%82%d0%b8%d0%b2-%d1%82%d1%83%d0%b1%d0%b5%d1%80%d0%ba%d1%83%d0%bb%d0%b5%d0%b7\/","title":{"rendered":"VACCINATION COVERAGE AGAINST TUBERCULOSIS AND OTHER PREVENTIVE VACCINATIONS OF CHILDREN BORN IN 2024 ACCORDING TO THE OUTPATIENT CLINIC DATA"},"content":{"rendered":"

Received: 08.12.2025
\nAccepted: 10.12.2025
\nPublished online: 31.12.2025
\nUDC: 616-053.2-084+615.371
\nDOI: 10.26212\/2227-1937.2025.21.20.006<\/a><\/p>\n

 <\/p>\n

VACCINATION COVERAGE AGAINST TUBERCULOSIS AND OTHER PREVENTIVE VACCINATIONS <\/strong>OF CHILDREN BORN IN 2024 ACCORDING TO THE OUTPATIENT CLINIC DATA<\/strong><\/p>\n

 <\/p>\n

Zh.O.Sarbassova \u00b9, B.N.Boketova \u00b9, U.A.Kalykova \u00b9, N.G.Chernikova \u00b9
\n\u00b9 Asfendiyarov Kazakh National Medical University, Almaty, Republic of Kazakhstan<\/p>\n

 <\/p>\n

Relevance<\/strong> of the study is determined by the increasing number of vaccine-preventable
\ninfections and the need to monitor vaccination coverage among children.<\/p>\n

The aim of the study<\/strong> was to assess the coverage and timeliness of preventive vaccinations,
\nincluding tuberculosis vaccination, among children born in 2024 and registered at the
\noutpatient clinic.<\/p>\n

Materials and Methods<\/strong>: A retrospective cross-sectional analysis of 204 child development
\nrecords (form No.112) was conducted manually, after which the data were reverified using
\nelectronic immunization records in the Registry, corresponding to form No.63.<\/p>\n

Results and Discussion<\/strong>. The results showed that 173 children (84,8%) received the
\ntuberculosis vaccine, and 180 children (88,2%) received the hepatitis B vaccine, 113 children
\n(55,4%) received the first dose of Infanrix-Hexa, 85 children (42%) received the second dose,
\nand Pentaxim was administered to 85 children (42%). Immunization with Prevenar: first dose
\n\u2014 116 children (57%), second dose \u2014 81 children (40%), third dose \u2014 34 children (17%). The
\nmeasles, rubella, and mumps (MMR) vaccine was given to 61 children (30%). OPV revaccination
\nwas performed in 23 children (11%).<\/p>\n

Conclusion<\/strong>: 84,8% children received the tuberculosis vaccine and 88,2% received the hepatitis
\nB vaccine. The insufficient coverage and delayed timing of vaccination against pneumococcal
\ninfection (third dose), measles, rubella, mumps, and poliomyelitis (fourth dose, revaccination)
\nare associated with children not having reached the recommended vaccination age, the
\npresence of medical contraindications, refusals, and unidentified reasons.<\/p>\n

Keywords<\/strong>: vaccination, coverage, the tuberculosis, vaccine BCG, children, immunization
\nschedule, timeliness, outpatient clinic.<\/p>\n

 <\/p>\n

\r\n\t\"\"\r\n\r\n\t
\r\n\t\t\u0421\u043a\u0430\u0447\u0430\u0442\u044c: VACCINATION COVERAGE AGAINST TUBERCULOSIS AND OTHER PREVENTIVE VACCINATIONS OF CHILDREN BORN IN 2024 ACCORDING TO THE OUTPATIENT CLINIC DATA<\/a>\r\n\t\t
<\/div>\r\n\t\t
\u0421\u043a\u0430\u0447\u0430\u043d\u043e: 51, \u0440\u0430\u0437\u043c\u0435\u0440: 0<\/div>\r\n\t<\/div>\r\n\t\r\n<\/div>\r\n\r\n